Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$709M |
| 2 |
Amazon
AMZN
|
+$653M |
| 3 |
Tesla
TSLA
|
+$457M |
| 4 |
Exxon Mobil
XOM
|
+$450M |
| 5 |
Uber
UBER
|
+$382M |
Top Sells
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$520M |
| 2 |
Netflix
NFLX
|
+$476M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$377M |
| 5 |
Apple
AAPL
|
+$374M |
Sector Composition
| 1 | Technology | 19.76% |
| 2 | Healthcare | 17.68% |
| 3 | Consumer Discretionary | 13.1% |
| 4 | Industrials | 7.95% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VOXR
3101
Vox Royalty Corp
VOXR
$178M
| $221K | ﹤0.01% |
107,067
+51,667
| +93% | +$107K |
|
|
EXPR
3102
DELISTED
Express, Inc.
EXPR
| $221K | ﹤0.01% |
26,385
-4,300
| -14% | -$36K |
|
3103
2x Long VIX Futures ETF
UVIX
$426M
| $220K | ﹤0.01% |
+1,600
| New | +$220K |
|
|
FRLN
3104
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
| $220K | ﹤0.01% |
34,460
+8,100
| +31% | +$51.7K |
|
3105
Mineralys Therapeutics
MLYS
$2.99B
| $219K | ﹤0.01% |
25,500
-70,190
| -73% | -$603K |
|
3106
NN Inc
NNBR
$121M
| $219K | ﹤0.01% |
54,800
+17,300
| +46% | +$69.1K |
|
|
TMQ
3107
Trilogy Metals
TMQ
$351M
| $219K | ﹤0.01% |
508,526
+257,026
| +102% | +$111K |
|
3108
Pulmatrix
PULM
$18.3M
| $218K | ﹤0.01% |
117,321
+6,056
| +5% | +$11.3K |
|
|
RTC
3109
DELISTED
Baijiayun Group
RTC
| $216K | ﹤0.01% |
21,579
-1,760
| -8% | -$17.6K |
|
3110
Cocrystal Pharma
COCP
$15M
| $215K | ﹤0.01% |
125,128
-1,100
| -0.9% | -$1.89K |
|
3111
JPMorgan BetaBuilders US Aggregate Bond ETF
BBAG
$1.29B
| $214K | ﹤0.01% |
+4,600
| New | +$214K |
|
3112
P3 Health Partners
PIII
$28.4M
| $214K | ﹤0.01% |
3,040
-4,216
| -58% | -$297K |
|
3113
ProKidney
PROK
$402M
| $214K | ﹤0.01% |
+120,000
| New | +$214K |
|
3114
Protara Therapeutics
TARA
$120M
| $212K | ﹤0.01% |
113,300
+53,200
| +89% | +$99.5K |
|
|
LGO
3115
Largo
LGO
$98.8M
| $211K | ﹤0.01% |
+91,400
| New | +$211K |
|
3116
Beyond Air
XAIR
$11.8M
| $211K | ﹤0.01% |
5,374
+2,294
| +74% | +$90.1K |
|
3117
Simply Good Foods
SMPL
$2.78B
| $210K | ﹤0.01% |
5,300
-800
| -13% | -$31.7K |
|
3118
Synlogic
SYBX
$17.5M
| $210K | ﹤0.01% |
+54,630
| New | +$210K |
|
3119
Celularity
CELU
$62.7M
| $209K | ﹤0.01% |
84,347
+30,007
| +55% | +$74.4K |
|
3120
CASI Pharmaceuticals
CASI
$36.6M
| $208K | ﹤0.01% |
29,100
+11,300
| +63% | +$80.8K |
|
|
VINC
3121
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $208K | ﹤0.01% |
8,801
+2,156
| +32% | +$51K |
|
3122
Marker Therapeutics
MRKR
$12.6M
| $207K | ﹤0.01% |
37,550
-2,700
| -7% | -$14.9K |
|
3123
Repay Holdings
RPAY
$487M
| $205K | ﹤0.01% |
23,951
-111,049
| -82% | -$950K |
|
3124
Harte-Hanks
HHS
$27.4M
| $204K | ﹤0.01% |
30,100
-8,200
| -21% | -$55.6K |
|
|
GHSI
3125
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
| $203K | ﹤0.01% |
38,020
-1,700
| -4% | -$9.08K |
|